October JAAD: Adalimumab in conjunction with surgery compared with adalimumab monotherapy for Hidradenitis Suppurativa: A randomized controlled trial in a real-world setting

AAD's Dialogues in Dermatology - Podcast tekijän mukaan American Academy of Dermatology

Pim Aarts, MD interviewed by Olayemi Sokumbi, MD, FAAD

Visit the podcast's native language site